Site-Specific Immunomodulator: A Novel Treatment for Crohn’s Disease
We investigated the mechanism of action, safety, and efficacy of the Site-Specific Immunomodulator (SSI) QBECO, a novel immunotherapy for Crohn’s disease (CD). Using human monocytic THP-1 cells, we demonstrate that SSI QBECO (derived from the common colon bacteria E. coli) activates macrophages to a...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2015-01-01
|
| Colecção: | Gastroenterology Research and Practice |
| Acesso em linha: | http://dx.doi.org/10.1155/2015/231243 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|